In a randomized, double-blind, placebo-controlled study, a DP2 antagonist (OC000459) was effective in reducing nasal and ocular symptoms in patients with allergic rhinitis caused by grass pollen [138]. Here, PTGDR2 is linked to allergic rhinitis.